Agilent Technologies 향후 성장

Future 기준 점검 2/6

Agilent Technologies (는) 각각 연간 9% 및 5.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 22.5% 로 예상됩니다.

핵심 정보

9.0%

이익 성장률

10.38%

EPS 성장률

Life Sciences 이익 성장	17.5%
매출 성장률	5.7%
향후 자기자본이익률	22.45%
애널리스트 커버리지	Good
마지막 업데이트	25 Nov 2025

최근 향후 성장 업데이트

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Nov 28

Recent updates

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Apr 24

Tariffs And Tactics: Agilent's Path Through Trade Disruption

Apr 07

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

Mar 01

Getting In Cheap On Agilent Technologies, Inc. (NYSE:A) Is Unlikely

Feb 24

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Feb 07

Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?

Jan 22

Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Dec 13

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Nov 28

Agilent Q4: Expecting Market Recovery In 2025

Nov 26

Strategic Expansion And Digital Innovation Poised To Catapult Growth In Life Sciences

Aug 29 Strategic acquisitions and innovation in biopharma and environmental testing highlight a focus on high-demand areas and regulatory changes, suggesting potential revenue growth.

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Aug 23

Agilent: Making A Move To Ignite Some Growth

Jul 25

이익 및 매출 성장 예측

NYSE:A - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
7/31/2025	6,788	1,220	1,088	1,495	N/A
4/30/2025	6,628	1,166	1,189	1,585	N/A
1/31/2025	6,533	1,259	1,312	1,697	N/A
10/31/2024	6,510	1,289	1,373	1,751	N/A
7/31/2024	6,497	1,413	1,417	1,786	N/A
4/30/2024	6,591	1,242	1,538	1,896	N/A
1/31/2024	6,735	1,236	1,649	1,961	N/A
10/31/2023	6,833	1,240	1,474	1,772	N/A
7/31/2023	6,994	1,133	1,420	1,704	N/A
4/30/2023	7,040	1,351	1,183	1,468	N/A
1/31/2023	6,930	1,323	1,061	1,353	N/A
10/31/2022	6,848	1,254	1,021	1,312	N/A
7/31/2022	6,659	1,328	1,022	1,305	N/A
4/30/2022	6,527	1,263	1,058	1,313	N/A
1/31/2022	6,445	1,205	1,280	1,502	N/A
10/31/2021	6,319	1,210	1,297	1,485	N/A
7/31/2021	6,142	990	1,268	1,421	N/A
4/30/2021	5,817	925	1,253	1,377	N/A
1/31/2021	5,530	810	1,092	1,218	N/A
10/31/2020	5,339	719	802	921	N/A
7/31/2020	5,223	691	736	858	N/A
4/30/2020	5,236	683	665	810	N/A
1/31/2020	5,236	764	598	749	N/A
10/31/2019	5,163	1,071	865	1,021	N/A
7/31/2019	5,090	1,072	N/A	1,079	N/A
4/30/2019	5,019	1,117	N/A	1,034	N/A
1/31/2019	4,987	1,140	N/A	1,085	N/A
10/31/2018	4,914	316	N/A	1,087	N/A
7/31/2018	4,809	298	N/A	1,003	N/A
4/30/2018	4,720	237	N/A	1,034	N/A
1/31/2018	4,616	196	N/A	988	N/A
10/31/2017	4,472	684	N/A	889	N/A
7/31/2017	4,394	633	N/A	835	N/A
4/30/2017	4,324	582	N/A	801	N/A
1/31/2017	4,241	509	N/A	798	N/A
10/31/2016	4,202	462	N/A	793	N/A
7/31/2016	4,126	476	N/A	800	N/A
4/30/2016	4,096	465	N/A	714	N/A
1/31/2016	4,040	466	N/A	643	N/A
10/31/2015	4,038	438	N/A	1,322	N/A
7/31/2015	4,046	306	N/A	1,245	N/A
4/30/2015	4,041	256	N/A	1,165	N/A
1/31/2015	4,066	204	N/A	1,307	N/A

애널리스트 향후 성장 전망

수입 대 저축률: A 의 연간 예상 수익 증가율(9%)이 saving rate(3.3%)보다 높습니다.

수익 vs 시장: A 의 연간 수익(9%)이 US 시장(16%)보다 느리게 성장할 것으로 예상됩니다.

고성장 수익: A 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: A 의 수익(연간 5.7%)이 US 시장(연간 10.5%)보다 느리게 성장할 것으로 예상됩니다.

고성장 매출: A 의 수익(연간 5.7%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: A의 자본 수익률은 3년 후 22.5%로 높을 것으로 예상됩니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/11/25 11:33
종가	2025/11/25 00:00
수익	2025/10/31
연간 수익	2025/10/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Agilent Technologies, Inc.는 33명의 분석가가 다루고 있습니다. 이 중 16명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Catherine Ramsey Schulte	Baird
Charles Butler	Barclays
Luke Sergott	Barclays

Agilent Technologies 향후 성장

Future 기준 점검 2/6

핵심 정보

최근 향후 성장 업데이트

Price target increased by 12% to US$168

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter of 2026 and Fiscal Year 2026

Agilent Technologies, Inc. Raises Earnings Guidance for the Full Fiscal Year 2025

Agilent Technologies, Inc. Revises Earnings Guidance for the Fiscal Full Year of 2025

Agilent Technologies, Inc. Provides Earnings Guidance for the Fiscal Second Quarter and Full Year of 2025

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Recent updates

Price target increased by 12% to US$168

Projecting Agilent's FY26: Can The Company Hit Its Ambitious Guidance?

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter of 2026 and Fiscal Year 2026

Third quarter dividend of US$0.26 announced

Agilent Technologies Inc. Announces Cash Dividend, Payable on Jan. 28, 2026

CEO, President & Director notifies of intention to sell stock

Agilent Technologies, Inc. to Report Q4, 2025 Results on Nov 24, 2025

Agilent Technologies, Inc. Announces Chief Financial Officer Changes

Now 27% overvalued after recent price rise

Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening

Agilent Technologies Inc. Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing

Third quarter dividend of US$0.25 announced

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 22, 2025

Third quarter 2025 earnings: EPS and revenues exceed analyst expectations

Agilent Technologies, Inc. Raises Earnings Guidance for the Full Fiscal Year 2025

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

Agilent Technologies, Inc. Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. to Report Q3, 2025 Results on Aug 27, 2025

What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

Upcoming dividend of US$0.25 per share

Agilent to Showcase New Products and Innovations At HPLC 2025

Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Agilent Technologies, Inc. Revises Earnings Guidance for the Fiscal Full Year of 2025

Agilent Technologies Inc. Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

First quarter dividend of US$0.25 announced

Agilent Announces Quarterly Cash Dividend, Payable on July 23, 2025

Agilent Technologies Inc. Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series

Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?

Agilent Technologies Inc. Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Tariffs And Tactics: Agilent's Path Through Trade Disruption

Agilent Technologies, Inc. Announces Resignation of Heidi Kunz as Member of the Board of Directors, Member of the Compensation Committee, and A Member of the Nominating/Corporate Governance Committee, Effective May 21, 2025

Upcoming dividend of US$0.25 per share

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Now 20% undervalued after recent price drop

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Now 20% undervalued after recent price drop

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

First quarter 2025 earnings: EPS misses analyst expectations

Agilent Technologies, Inc. Provides Earnings Guidance for the Fiscal Second Quarter and Full Year of 2025

Getting In Cheap On Agilent Technologies, Inc. (NYSE:A) Is Unlikely

Fourth quarter dividend of US$0.25 announced

Agilent Announces Quarterly Cash Dividend, Payable on April 23, 2025

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. to Report Q1, 2025 Results on Feb 26, 2025

Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?

Agilent Technologies, Inc., Annual General Meeting, Mar 13, 2025

Upcoming dividend of US$0.25 per share

Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Insufficient new directors

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Agilent Q4: Expecting Market Recovery In 2025

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025

Third quarter dividend increased to US$0.25

Agilent Technologies, Inc. Increases Quarterly Cash Dividend, Payable on January 22, 2025

Agilent Technologies, Inc. Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research

Agilent Technologies, Inc. to Report Q4, 2024 Results on Nov 25, 2024

Insider notifies of intention to sell stock

Third quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on October 23, 2024

Strategic Expansion And Digital Innovation Poised To Catapult Growth In Life Sciences

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Agilent Technologies, Inc. Provides Financial Guidance for the Fourth Quarter of Fiscal 2024 and Revised Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance